Literature DB >> 5121647

Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

R J Kociba, S D Sleight.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5121647

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  31 in total

1.  Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum (II), CDDP) in BD IX rats.

Authors:  S R Kempf; S Ivankovic
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Pattern of toxicity by titanocene dichloride in mice. Blood and urine chemical parameters.

Authors:  P Köpf-Maier; S Gerlach
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide.

Authors:  H T Heidemann; J F Gerkens; E K Jackson; R A Branch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

Review 4.  Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.

Authors:  Darren Lars Stirland; Joseph W Nichols; Seiji Miura; You Han Bae
Journal:  J Control Release       Date:  2013-10-02       Impact factor: 9.776

5.  Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats.

Authors:  S Sugimoto; Y L Yamamoto; S Nagahiro; M Diksic
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Cisplatin-associated anemia: an erythropoietin deficiency syndrome.

Authors:  P A Wood; W J Hrushesky
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Urinary gamma-glutamyl transferase as an indicator of acute nephrotoxicity in rats.

Authors:  P J Dierickx
Journal:  Arch Toxicol       Date:  1981-06       Impact factor: 5.153

8.  Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.

Authors:  C L Bregman; P D Williams
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Bullatacin--in vivo and in vitro experience in an ovarian cancer model.

Authors:  C H Holschneider; M T Johnson; R M Knox; A Rezai; W J Ryan; F J Montz
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II).

Authors:  P E Gormley; D Gangji; J H Wood; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.